← Back to Screener
Intelligent Bio Solutions Inc. Common Stock (INBS)
Price$2.45
Growth ScoreA
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-70.80%
Price vs S&P 500 (4W)3.82%
VGM Score53.86
Market Capitalization$5.86M
All Metrics
Book Value / Share (Quarterly)$4.48
P/TBV (Annual)1.44x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)91.13%
Cash Flow / Share (Quarterly)$-5.65
Price vs S&P 500 (YTD)-82.45%
Gross Margin (TTM)47.25%
Net Profit Margin (TTM)-296.77%
EPS (TTM)$-12.52
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-12.52
Revenue Growth (5Y)74.49%
EPS (Annual)$-20.04
ROI (Annual)-330.97%
Gross Margin (Annual)40.85%
Net Profit Margin (5Y Avg)-754.73%
Cash / Share (Quarterly)$3.43
Revenue Growth QoQ (YoY)45.54%
ROA (Last FY)-128.11%
Revenue Growth TTM (YoY)33.26%
EBITD / Share (TTM)$-10.25
ROE (5Y Avg)-185.33%
Operating Margin (TTM)-298.58%
Cash Flow / Share (Annual)$-13.53
P/B Ratio0.65x
P/B Ratio (Quarterly)0.75x
Net Income / Employee (Annual)$-660,500
EV / Revenue (TTM)-0.26x
Net Interest Coverage (TTM)-3.75x
ROA (TTM)-91.44%
EPS Incl Extra (Annual)$-20.04
Current Ratio (Annual)0.77x
Quick Ratio (Quarterly)1.98x
3-Month Avg Trading Volume0.12M
52-Week Price Return-84.34%
Revenue / Employee (TTM)$244,600
Tangible BV / Share (Quarterly)$2.98
P/S Ratio (Annual)1.92x
Asset Turnover (Annual)0.37x
52-Week High$24.90
Operating Margin (5Y Avg)-773.91%
EPS Excl Extra (Annual)$-20.04
26-Week Price Return-62.88%
Quick Ratio (Annual)0.59x
13-Week Price Return-42.76%
Total Debt / Equity (Annual)0.07x
Current Ratio (Quarterly)2.11x
Enterprise Value$-1.00M
Revenue / Share Growth (5Y)1.72%
Asset Turnover (TTM)0.31x
Revenue / Employee (Annual)$190,800
Pretax Margin (Annual)-347.41%
Cash / Share (Annual)$1.39
3-Month Return Std Dev116.96%
Net Income / Employee (TTM)$-725,800
ROE (Last FY)-352.74%
Net Interest Coverage (Annual)-110.59x
EPS Basic Excl Extra (Annual)$-20.04
Receivables Turnover (TTM)5.63x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-12.52
Receivables Turnover (Annual)0.76x
ROI (TTM)-171.91%
P/S Ratio (TTM)1.50x
Pretax Margin (5Y Avg)-757.22%
Revenue / Share (Annual)$5.79
Tangible BV / Share (Annual)$11.45
Forward P/E0.70x
Price vs S&P 500 (52W)-108.71%
Year-to-Date Return-74.29%
5-Day Price Return-1.21%
EPS Normalized (Annual)$-20.04
ROA (5Y Avg)-80.78%
Net Profit Margin (Annual)-346.23%
Month-to-Date Return-4.67%
Cash Flow / Share (TTM)$-7.57
EBITD / Share (Annual)$-17.89
Operating Margin (Annual)-348.71%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-170.27%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-12.52
P/TBV (Quarterly)1.12x
P/B Ratio (Annual)4.20x
Inventory Turnover (TTM)3.22x
Pretax Margin (TTM)-297.81%
Book Value / Share (Annual)$4.09
Price vs S&P 500 (13W)-51.01%
Beta4.20x
Revenue / Share (TTM)$2.45
ROE (TTM)-174.17%
52-Week Low$2.24
gGradeA
mGradeF
vgmGradeC
Show chart for
Analyst Recommendations
Dec 2024
Jan 2025
Feb 2025
Mar 2025
4.29
4.29
4.29
4.29
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
INBSIntelligent Bio Solutions Inc. Common Stock | — | A | F | $2.45 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive diagnostic tests, including a biosensor platform for chronic disease monitoring and a portable drug screening solution that analyzes fingerprint sweat. The company's products offer real-time, hygienic alternatives to traditional diagnostic and substance screening methods. It operates across four geographic segments—United Kingdom, Asia Pacific, Americas, and Rest of World—with the United Kingdom representing its largest revenue source.